Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Samuel Osamu Mayeda , MD

Specialist • Orange, CA

Active NPI 1487716544 Individual Practitioner Male Practitioner
Practice location in NPPES

1140 W La Veta Ave Ste 420
Orange, CA 928684226

Call 7142851904 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1140 W La Veta Ave Ste 420

Orange, CA 928684226

Telephone 7142851904
Fax 7145715979
Organization at the Same NPPES Address or Phone
Endocrine Consultants And Specialists Medical Group Inc Facility NPI 1770666828

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare patients

185 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $150,187 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $111,331 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

9,823 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$3,638,281 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $550.65 across 23 records.

By nature of payment

  • Food and Beverage: $550.65 across 23 records.

Reporting-company totals (3 largest of 18)

  • Novartis Pharmaceuticals Corporation: $80.86 across 3 records.
  • Insulet Corporation: $43.74 across 1 record.
  • Boehringer Ingelheim Pharmaceuticals, Inc.: $40.49 across 2 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Medicare assignment not listed

CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Mayeda has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Mayeda as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Orange and California

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 65% of clinicians listed under Specialist in Orange, CA (2024, 16 clinicians with data). Median for this group: 1,338. Middle half: 156 to 3,295.

More Medicare Part B services than 60% of clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: 1,451. Middle half: 399 to 4,264.

Medicare-allowed amount

A higher Medicare-allowed amount than 60% of clinicians listed under Specialist in Orange, CA (2024, 16 clinicians with data). Median for this group: $80,767. Middle half: $24,629 to $236,738.

Close to the middle for clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: $122,735. Middle half: $39,934 to $306,970.

Paid by Medicare

A higher Medicare payment amount than 60% of clinicians listed under Specialist in Orange, CA (2024, 16 clinicians with data). Median for this group: $64,298. Middle half: $18,306 to $180,294.

Close to the middle for clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: $93,704. Middle half: $29,348 to $234,121.

Medicare Part D prescriptions

More Part D prescriptions than 80% of clinicians listed under Specialist in Orange, CA (2024, 14 clinicians with data). Median for this group: 703. Middle half: 324 to 3,659.

More Part D prescriptions than 85% of clinicians listed under Specialist in California (2024, 1,050 clinicians with data). Median for this group: 502. Middle half: 100 to 1,752.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Specialist in Orange, CA (2024, 14 clinicians with data). Median for this group: $57,261. Middle half: $2,940 to $735,045.

A higher Part D drug cost than 95% of clinicians listed under Specialist in California (2024, 1,050 clinicians with data). Median for this group: $36,643. Middle half: $2,246 to $302,438.

49 active clinicians are listed under Specialist with a practice address in Orange, CA (5,763 in California).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Orange

10.2% of these 49 clinicians have the CMS telehealth indicator.

32.7% of these 49 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $550.65.

Manufacturer Payment Nature Product Type Amount ($)
Insulet Corporation
Food and Beverage
Cash or cash equivalent
Omnipod General $43.74
Sandoz Inc.
Food and Beverage
In-kind items and services
— General $32.07
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
LEQVIO General $31.73
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
Kerendia General $31.61
Exact Sciences Corporation
Food and Beverage
In-kind items and services
Cologuard Collection Kit General $31.10
ABBVIE INC.
Food and Beverage
In-kind items and services
QULIPTA General $29.81
RECORDATI_RARE_DISEASES_INC.
Food and Beverage
In-kind items and services
ISTURISA General $27.06
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
LEQVIO General $27.05
KYOWA KIRIN, INC.
Food and Beverage
In-kind items and services
CRYSVITA General $26.67
Esperion Therapeutics, Inc.
Food and Beverage
In-kind items and services
NEXLETOL General $24.87
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
LEQVIO General $22.08
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
JARDIANCE General $21.93
Eli Lilly and Company
Food and Beverage
In-kind items and services
MOUNJARO General $21.91
Radius Health, Inc.
Food and Beverage
In-kind items and services
Tymlos General $21.05
Corcept Therapeutics
Food and Beverage
In-kind items and services
Korlym General $19.25
Xeris Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
RECORLEV General $18.87
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
JARDIANCE General $18.56
Boston Scientific Corporation
Food and Beverage
In-kind items and services
WaveWriter Alpha Prime 16 General $18.40
Amgen Inc.
Food and Beverage
In-kind items and services
REPATHA General $17.49
IBSA Pharma Inc.
Food and Beverage
Cash or cash equivalent
Tirosint General $17.02
Amgen Inc.
Food and Beverage
In-kind items and services
REPATHA General $16.69
IBSA Pharma Inc.
Food and Beverage
Cash or cash equivalent
Tirosint General $16.55
TOLMAR, INC.
Food and Beverage
In-kind items and services
JATENZO General $15.14

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
722 38 $75.00 $41.40
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
501 162 $225.00 $135.03
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
352 38 $75.00 $52.46
36415 Insertion of needle into vein for collection of blood sample
308 105 $22.00 $8.65
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
286 36 $100.00 $54.01
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
45 42 $275.00 $190.38
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
29 21 $50.00 $33.25
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
20 16 $110.00 $57.24
90662 Influenza vaccine split virus, preservative free
13 13 $86.92 $81.82
G0008 Administration of influenza virus vaccine
13 13 $60.00 $35.02
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
12 11 $75.00 $15.28
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
12 12 $190.00 $96.29
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
11 11 $510.00 $230.46

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Levothyroxine Sodium Levothyroxine Sodium 323 27,852 $4,170.48 79
Ezetimibe Ezetimibe 234 19,378 $8,350.77 66
Rosuvastatin Calcium Rosuvastatin Calcium 183 15,959 $2,955.97 60
Amlodipine Besylate Amlodipine Besylate 162 14,563 $1,865.21 53
Telmisartan Telmisartan 128 10,615 $5,624.82 36
Atorvastatin Calcium Atorvastatin Calcium 125 10,537 $1,266.75 39
Metformin Hcl Metformin Hcl 125 10,500 $1,216.14 32
Ozempic Semaglutide 125 4,906 $147,465.95 23
Synthroid Levothyroxine Sodium 124 10,166 $12,686.64 32
Mounjaro Tirzepatide 87 3,898 $137,415.53 16
Glimepiride Glimepiride 82 7,380 $961.99 27
Pantoprazole Sodium Pantoprazole Sodium 81 6,278 $1,362.16 21
Losartan Potassium Losartan Potassium 72 5,940 $659.21 22
Allopurinol Allopurinol 71 6,314 $792.10 21
Jardiance Empagliflozin 57 3,840 $73,048.14 19
Nano 2nd Gen Pen Needle Pen Needle, Diabetic 53 3,910 $7,601.73 20
Azithromycin Azithromycin 52 253 $257.93 31
Clopidogrel Clopidogrel Bisulfate 52 4,590 $705.67 15
Omeprazole Omeprazole 51 4,370 $658.39 14
Doxazosin Mesylate Doxazosin Mesylate 48 4,117 $999.53 15
Lisinopril Lisinopril 41 3,700 $389.07 14
Metformin Hcl Er Metformin Hcl 41 3,330 $510.09 13
Farxiga Dapagliflozin Propanediol 41 2,924 $48,956.46 12
Toujeo Solostar Insulin Glargine,hum.Rec.Anlog 40 2,396 $21,538.99 —
Bupropion Xl Bupropion Hcl 35 2,790 $3,155.05 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Specialist Primary Specialty

NUCC Taxonomy Code: 174400000X

License # reported to NPPES CA C36879

An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Medical Board of California.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - ENDOCRINOLOGY

Medicare Enrollment ID

I20120307000102

Enrollment State Jurisdiction

CA

PECOS Control ID

7113186479

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Career & Practice History

NPI enumerated December 15, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1487716544
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: December 15, 2006
Last Update: July 08, 2007
Sole Proprietor: Yes

Other Specialists in Orange

All Specialists in Orange

Mailing Address

1140 W La Veta Ave Ste 420

Orange, CA 928684226

Phone: 7142851904

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.